OtoNexus Medical Technologies

Executive Summary

OtoNexus Medical Technologies is a Seattle-based medical device company specializing in advanced ultrasound otoscopes for the diagnosis of middle ear infections (otitis media). Founded in 2015, the company has developed a proprietary through-air ultrasound technology that provides clinicians with real-time, objective data to differentiate between bacterial and viral infections, thereby enabling more informed antibiotic prescribing decisions. This innovation addresses a critical unmet need in pediatric care, where acute otitis media is the leading cause of antibiotic prescriptions, many of which are unnecessary. By reducing diagnostic uncertainty, OtoNexus's device has the potential to improve patient outcomes and combat antibiotic resistance. The company operates in the diagnostics and medical devices sectors and is currently privately held, with no disclosed funding or valuation. While specific revenue and regulatory milestones are not publicly available, the technology's clinical relevance suggests strong market potential pending successful commercialization and regulatory clearance.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) Clearance for Ultrasound Otoscope70% success
• Q4 2026Publication of Clinical Validation Study Results60% success
• Q1 2027Series A Financing Round Completion50% success